Z-1518-2025 Class II Ongoing

Recalled by BioFire Diagnostics, LLC — Salt Lake City, UT

FDA device recall Z-1518-2025 was initiated by BioFire Diagnostics, LLC on Feb 27, 2025 and is designated Class II. Reason for recall: Increased risk of control failures and false negative test results with multiplexed nucleic acid test. The recall status is ongoing. Affected quantity: 29 kits.

Recall details

Product Type
Devices
Report Date
Apr 16, 2025
Initiation Date
Feb 27, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29 kits

Product description

FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374

Reason for recall

Increased risk of control failures and false negative test results with multiplexed nucleic acid test.

Distribution pattern

OUS International Distribution to countries of: France, Italia, Spain, Switzerland, Israel

Code information

UDI: 00815381020314/Lot# 0979424

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1518-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1518-2025. Report a data issue: hello@regdatalab.com.